KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares RepurchasedShort-Term Debt repayments
Ratios

Elevance Health (ELV) Shares Repurchased (2017 - 2025)

Elevance Health (ELV) has disclosed Shares Repurchased for 16 consecutive years, with $471.0 million as the latest value for Q4 2025.

  • On a quarterly basis, Shares Repurchased fell 73.99% to $471.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was $2.6 billion, a 10.17% decrease, with the full-year FY2025 number at $2.6 billion, down 10.17% from a year prior.
  • Shares Repurchased was $471.0 million for Q4 2025 at Elevance Health, down from $876.0 million in the prior quarter.
  • In the past five years, Shares Repurchased ranged from a high of $1.8 billion in Q4 2024 to a low of $60.0 million in Q3 2024.
  • A 5-year average of $622.6 million and a median of $545.0 million in 2022 define the central range for Shares Repurchased.
  • Peak YoY movement for Shares Repurchased: tumbled 87.5% in 2024, then surged 1360.0% in 2025.
  • Elevance Health's Shares Repurchased stood at $522.0 million in 2021, then rose by 10.92% to $579.0 million in 2022, then soared by 60.28% to $928.0 million in 2023, then skyrocketed by 95.15% to $1.8 billion in 2024, then plummeted by 73.99% to $471.0 million in 2025.
  • Per Business Quant, the three most recent readings for ELV's Shares Repurchased are $471.0 million (Q4 2025), $876.0 million (Q3 2025), and $378.0 million (Q2 2025).